At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
liposomal bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subcostal TAP Block With Liposomal Bupivacaine vs Bupivacaine in Donor Nephrectomy Patients: A Prospective Randomized Study
In Brief
A Phase 4 clinical trial evaluating liposomal bupivacaine and bupivacaine for Acute Pain. Completed, enrolled 60 participants.
Detailed Summary
The primary objective of this study is whether one local anesthetic, liposomal bupivacaine, provides improved pain control and decreased opioid use compared to bupivacaine when injected during a transversus abdominis plane block for donor nephrectomy patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
Primary CompletionJul 2014
Study CompletionOct 2014
First PostedNov 2014
TodayJul 2026
First PostedNov 11, 2014
Enrollment StartMay 1, 2013
Primary CompletionJul 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.6 years ago
Interventions
liposomal bupivacainedrug
patients will receive a tap with liposomal bupivacaine
bupivacainedrug
patients will receive a tap with bupivacaine